Global Tissue Transplant Market Size, Share, Opportunities, and Trends by Tissue Type (Cornea, Skin, Bone Marrow, Others), By Type of Graft (Autograft, Allograft, Xenograft), And By Geography – Forecast From 2025 To 2030

Tissue Transplant Market Size:

The global tissue transplant market is expected to grow from USD 10.016 billion in 2025 to USD 14.391 billion in 2030, at a CAGR of 7.52%.

Chronic disorders frequently result in severe organ damage. This damage is frequently irreparable, resulting in lifelong reliance on medications. Transplants are the only way to restore a healthy life under such extreme circumstances. Tissue transplants, also known as grafts, are procedures in which a tissue or a piece of tissue is transplanted from its original location to the area of interest in an individual (same or separate). As a result, the new and healthy environment nurtures the transplanted graft.

One of the primary factors boosting the worldwide tissue transplant market in the foreseeable period is the rise of chronic diseases such as diabetes, cancer, cardiovascular disease, renal disease, and Alzheimer's disease has put a large population at risk of permanent tissue damage. Furthermore, the market is being driven by rising health awareness and government activities related to tissue donation. Additionally, the fact that skin, cornea, bones, heart valves, tendons, nerves, and veins are the most routinely performed procedures worldwide is driving the market growth. The rising number of burn and injury cases will likely drive tissue product demand. In Spain, 102,362 injury accidents were documented, according to the European Road Safety Observatory study. As a result, there is a demand for tissue transplantation. Moreover, technological developments will fuel market expansion in the next years, creating opportunities.

However, the worldwide tissue transplant market's growth may be hampered by transplant rejection throughout the forecast period. In addition, a lack of awareness about tissue transplantation is limiting market expansion.

Tissue Transplant Market Drivers:

• Because of the rising frequency of burns and acid damage in accidents, the skin segment is expected to hold a significant proportion of the market.

Extensive injury or damage can also be treated with skin grafts. A tiny patch of skin is removed from a patient's body part and joined to or transplanted to the damaged area of the body using skin from another part of the patient's body during a skin grafting process. The skin patch is transplanted or connected to the burnt or wounded area. Furthermore, the rising prevalence of skin cancer and diabetes is also accelerating market growth.

• During the projection period, the allograft segment is expected to grow at a significant CAGR.

Allograft is the transplantation of an organ, tissue, or cells from one person to another person of the same species who is not an identical twin. The improved treatment outcomes in patients due to allograft goods are credited with the segmental increase. Furthermore, market participants are concentrating on various methods to extend their product offerings in the allograft segment, which will drive segmental expansion in the future years. For example, Stryker and AlloSource announced the launch of ProChondrix CR, an osteochondral allograft for articular cartilage repair patients, in 2018.

Tissue Transplant Market Geographical Outlook:

• North America is expected to take the lead in terms of market share.

This region's dominance can be attributed to a well-developed healthcare infrastructure as well as regional leaders. Another vital component in the region's development is the introduction of new products. Lupin offered Tacrolimus, an immunosuppressive medicine, in the United States in November 2020 in collaboration with Concord Biotech. Europe is the second-largest market due to its spending on R&D for its activities. This, together with the region's enormous patient population, is expected to fuel growth over the predicted period.

Global Tissue Transplant Market Segmentation

• By Tissue Type
  • Cornea
  • Skin
  • Bone Marrow
  • Others
• By Graft Type
  • Autograft
  • Allograft
  • Xenograft
• By End-User
  • Hospitals
  • Surgical Centers
  • Others
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Taiwan
    • Others

---

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL TISSUE TRANSPLANT MARKET BY TISSUE TYPE

5.1. Introduction

5.2. Cornea

5.3. Skin

5.4. Bone Marrow

5.5. Others

6. GLOBAL TISSUE TRANSPLANT MARKET BY GRAFT TYPE

6.1. Introduction

6.2. Autograft

6.3. Allograft

6.4. Xenograft

7. GLOBAL TISSUE TRANSPLANT MARKET BY END-USER

7.1. Introduction

7.2. Hospitals

7.3. Surgical Centers

7.4. Others

8. GLOBAL TISSUE TRANSPLANT MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. USA

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. Germany

8.4.2. France

8.4.3. United Kingdom

8.4.4. Spain

8.4.5. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. China

8.6.2. India

8.6.3. Japan

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Competitive Dashboard

10. COMPANY PROFILES

10.1. Pinnacle Transplant Technologies, Inc.

10.2. CryoLife, Inc (Artivion Inc)

10.3. RTI Surgical Holdings, Inc.

10.4. CBR Systems, Inc.

10.5. Zimmer Biomet

10.6. XVIVO

10.7. Arthrex, Inc. 

10.8. Stryker Corporation

10.9. Medtronic PLC

11. APPENDIX

11.1. Currency 

11.2. Assumptions

11.3. Base and Forecast Years Timeline

11.4. Key benefits for the stakeholders

11.5. Research Methodology 

11.6. Abbreviations 

Pinnacle Transplant Technologies, Inc.

CryoLife, Inc (Artivion Inc)

RTI Surgical Holdings, Inc.

CBR Systems, Inc.

Zimmer Biomet

XVIVO

Arthrex, Inc. 

Stryker Corporation

Medtronic PLC